Mithras Investment Trust (MTH) Share Price, News & Analysis

Company Overview

Mithras Investment Trust PLC is a private equity investment trust. The Company's segments include Investment holdings and Private equity fund-of-funds management. Its investment objective is to follow a realization strategy, which aims to crystallize value for shareholders in a manner, which seeks to achieve a balance between returning cash to shareholders and maximizing value of the Company's portfolio. Its investment portfolio consists of a commitment to Mithras Capita Fund LP (MCF), which is invested in the European and the United States-based limited partnership buyout funds. It invests in sectors, such as food and beverage; healthcare; travel, leisure and retail; industrial goods and services; building materials and others; basic resources; telecommunications, media and technology; financial services and insurance, and oil, gas and chemicals. It operates in Continental Europe, North America, Asia and the United Kingdom. Its investment manager is Mithras Capital Partners LLP.

Key Stats

• Today's Range: N/A
• 50-Day Range: 241 to 241
• 52-Week Range: N/A
• Volume: 553 shs
• Average Volume: 2,288 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MTH Stock Analysis - Frequently Asked Questions

How do I buy shares of Mithras Investment Trust?

Shares of MTH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Mithras Investment Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Mithras Investment Trust investors own include bluebird bio (BLUE), Argonaut Gold (AR), Athene (ATH), BELLUS Health (BLU), Esperion Therapeutics (ESPR), Fortress Biotech (FBIO) and Forte Biosciences (FBRX).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Construction
• Industry: New Single - Family Housing Construction (Except For - Sale Builders)
• Sub-Industry: Construction
• Current Symbol: LON:MTH
• CUSIP: N/A
• CIK: N/A
• Web: www.mithrascapital.com
• Phone: +44-20-78725650
• Fax: N/A
• Employees: 1,920
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A